Stockscreener 앱 받기
2.97
2.77%
0.08
전일 마감가:
$2.89
열려 있는:
$2.9
하루 거래량:
4,673
Relative Volume:
0.15
시가총액:
$66.42M
수익:
$35.16M
순이익/손실:
$-11.44M
주가수익비율:
-4.9824
EPS:
-0.5961
순현금흐름:
$-15.44M
1주 성능:
+3.85%
1개월 성능:
-6.90%
6개월 성능:
-45.35%
1년 성능:
-57.91%
1일 변동 폭
$2.89
$3.0499
1주일 범위
$2.87
$3.0499
52주 변동 폭
$2.745
$12.80
Bioharvest Sciences Inc Stock (BHST) Company Profile
Compare BHST vs JBS, KHC, GIS, MKC, HRL
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
2.93 | 65.51M | 35.16M | -11.44M | -15.44M | -0.5961 |
JBS
Jbs Nv
|
12.19 | 40.32B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
25.34 | 30.08B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
36.97 | 20.05B | 18.37B | 2.22B | 1.65B | 4.0676 |
MKC
Mccormick Co Inc
|
52.35 | 14.37B | 7.11B | 1.65B | 680.40M | 6.1005 |
HRL
Hormel Foods Corp
|
24.64 | 13.76B | 12.22B | 466.64M | 692.94M | 0.8477 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-19 | 개시 | Roth Capital | Buy |
| 2025-05-05 | 개시 | Craig Hallum | Buy |
| 2024-12-18 | 개시 | Maxim Group | Buy |
Bioharvest Sciences Inc 주식(BHST)의 최신 뉴스
BioHarvest Sciences Inc. Q1 2025 Earnings: Wider Loss per Share Misses Analyst ExpectationsCapex Guidance - dars.gov.et
BHSTBioHarvest Sciences Inc Latest SEC Filings - Finviz
BioHarvest Sciences (BHST) Rebounds 1.75% as Buyers Defend Key Support ZoneNAAIM Leverage - dars.gov.et
BioHarvest Sciences, Inc. Actuals & Estimates (MUN:8MV0) - TradingView
BioHarvest Sciences Inc. (BHST) reports Q1 loss, beats revenue estimates - MSN
BioHarvest Sciences, Inc. Actuals & Estimates (NASDAQ:BHST) - TradingView
8MV0 Forecast — Price Target — Prediction for 2027 - TradingView
Bioharvest Sciences Inc (BHST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioHarvest Sciences, Inc. Actuals & Estimates (DUS:8MV0) - TradingView
BioHarvest Sciences, Inc. Actuals & Estimates (LS:A40C6G) - TradingView
Bioharvest Sciences Inc (BHST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bioharvest Sciences Inc (BHST) Institutional Confidence - TradingKey
Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Miss Signals Continued Investment in GrowthEarnings Quality Score - dars.gov.et
BioHarvest Sciences to Showcase Botanical Synthesis at 2026 BIO International Convention - The Globe and Mail
BioHarvest Sciences (BHST) to showcase Botanical Synthesis at 2026 BIO Convention - Stock Titan
Bioharvest Sciences Inc (BHST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bioharvest Sciences Inc (BHST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioHarvest brings its plant-based tech to BIO International in San Diego - Stock Titan
BioHarvest Sciences to present botanical synthesis platform at BIO International Convention - Proactive financial news
Bioharvest Sciences Inc (BHST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bioharvest Sciences Inc (BHST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bioharvest Sciences Inc (BHST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioHarvest Sciences Inc. Q1 2025 Earnings: EPS Misses Estimates Amid Operational ProgressRevenue Growth Report - dars.gov.et
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Misses Estimates as Company Continues Strategic AdvancementManagement Guidance Update - newsline.com
BHST PE Ratio & Valuation, Is BHST Overvalued - Intellectia AI
BioHarvest Sciences Q1 2025 Earnings: EPS Misses Estimates While Stock Sees Positive ReactionSegment Revenue Breakdown - newsline.com
BioHarvest Sciences Inc. (BHST) Advances 2.75% as Shares Hold Above Key SupportLong Setup Ideas - newsline.com
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: Higher Losses Weigh on Operational ProgressEarnings Preview - newsline.com
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: BioHarvest Sciences (BHST) and Brown Forman A (BF.A) - The Globe and Mail
BioHarvest Sciences (BHST) Gains Nearly 1% as Shares Test Key ResistanceUp Down Ratio - newsline.com
Craig-Hallum Maintains BioHarvest Sciences(BHST.US) With Buy Rating - Moomoo
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Misses Estimates, Stock DeclinesPerformance Review - newsline.com
BHST Q1 2025 Earnings: EPS Misses Estimates, Stock DeclinesEarnings Revision Upgrade - newsline.com
BioHarvest (BHST) Q4 2025 Earnings Transcript - AOL.com
BioHarvest Sciences (BHST) Retreats to Key Support Level After Modest DeclineElliott Wave Count - newsline.com
BioHarvest Sciences Files Form 6-K With Meeting Materials for Upcoming Shareholder Vote - TipRanks
BioHarvest Sciences (BHST) schedules 2026 AGM to elect board and ratify auditor - Stock Titan
BioHarvest Sciences Inc. (BHST) Edges Higher as Price Approaches Resistance After Support TestHigh Dividend Factor - The Legal Advocate
Tate & Lyle expands BioHarvest partnership for next-gen sweetener innovation - FoodTechBiz
BioHarvest Sciences Inc. (BHST) Edges Higher as Trading Volume Picks UpPercent Above MA - The Legal Advocate
BioHarvest Sciences Inc. (BHST) Finds Support, Bounces to $3.86Double EMA - The Legal Advocate
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation - TMX Newsfile
BioHarvest Sciences (BHST) Q1 2025 Earnings: EPS Misses Estimates as Company Navigates Early-Stage CommercializationRevenue Inflection Point - The Legal Advocate
Bioharvest Sciences Signals Progress Amid Near-Term Losses - TipRanks
BioHarvest Sciences and Tate & Lyle expand sweetener development program - Yahoo! Finance Canada
Tate & Lyle expands collaboration with BioHarvest to accelerate next-generation sweetener innovation - Asia Food Journal
BioHarvest (BHST) Q1 2026 Earnings Transcript - AOL.com
BioHarvest expands Tate & Lyle sweetener development deal By Investing.com - Investing.com Australia
Bioharvest Sciences Inc (BHST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.18%
0.08%
자본화:
|
볼륨(24시간):